fbpx

Newsroom

Welcome to the IVX Health Newsroom. Here, you can find the latest news on our company, including future market expansions, leadership updates, new formulary offerings and more.

NASHVILLE, Tenn. and BOSTON, Mass., Sep. 21, 2021 /Business Wire/ -- IVX Health, a national provider of outpatient infusion centers, announced today the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

NASHVILLE, Tenn., Sep. [17], 2021 /PRNewswire/ — Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2021, an annual program that identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide. Modern Healthcare ranked IVX Health No. 48 overall in one of its two category designations. The award marks the third consecutive year IVX Health has been recognized in the prestigious Best Places to Work list.

INDIANAPOLIS, Feb. 16, 2021 - IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn’s disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of three new centers in the Indianapolis metropolitan area.

IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of two new centers in the Chicago metropolitan area. Conveniently located in the communities of Lombard and Naperville, IVX Health offers patients an alternative to hospital-based infusions – with the same high-quality standards and safety protocols. IVX Health reimagines the traditional experience for infusion patients with amenities such as guaranteed private suites that allow for proper social distancing – a meaningful benefit when considering the often hours-long infusion procedures. IVX Health is now accepting patients in both of its new Chicago locations, adding to its existing footprint of Chicago-based centers conveniently located in Glenview and Schaumburg.

October 14th, 2020–IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, announced today its acquisition of Precision Healthcare, formerly a subsidiary of BAI Healthcare Services, Inc. Based in Nashville, Tenn., Precision operates 12 infusion centers across Tennessee and northern Arkansas. The acquisition financing was led by a preferred equity investment from Linden Capital Partners – a Chicago-based private equity firm focused exclusively on the healthcare sector – and joined by existing institutional investors McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2020, an annual program that identifies and honors 150 outstanding employers in the healthcare industry nationwide. Modern Healthcare ranked IVX Health No. 20 overall in one of its two category designations.

IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Tampa metropolitan area.

IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the Orlando metropolitan area.

July 22nd, 2020–IVX Health, a national provider of infusion and injection therapy for patients with autoimmune disorders such as multiple sclerosis and other complex chronic conditions, today announced the expansion of its infusion formulary with the addition of VYEPTI™ (eptinezumab-jjmr), the first FDA-approved IV preventive treatment for migraines in adults.

IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the Cincinnati metropolitan area.

Media Inquiries

Chase Pattison
Vice President, Marketing
[email protected]

Headquarters

IVX Health
214 Centerview Drive
Suite 250
Brentwood, TN 37027

Click here to find an IVX Health center near you.

Menu